Zicon

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Zicon

What is Zicon?

Ziconotide is a synthetic form of a peptide found in the venom of the Conus magus (magician’s cone) marine snail. It belongs to a class of medications known as non-opioid analgesics and is specifically categorized as a selective N-type voltage-gated calcium channel blocker.

Mechanism of Action

In the body, pain signals are transmitted via nerves to the spinal cord and then to the brain. This process involves the release of neurotransmitters, which act as chemical messengers. Ziconotide works by binding to specific calcium channels located on the primary nociceptive (pain-sensing) neurons in the spinal cord.

By blocking these channels, the medication inhibits the release of pro-nociceptive neurotransmitters, such as glutamate and substance P. This action effectively interrupts the transmission of pain signals before they reach the brain, thereby reducing the perception of chronic pain.

Clinical Application

Ziconotide is used for the management of severe chronic pain in patients for whom other treatments, such as systemic analgesics or adjunctive therapies, have proven ineffective or result in intolerable side effects. Because it does not bind to opioid receptors, it does not carry the same risks of respiratory depression or traditional opioid physical dependence.

Administration Method

Due to its chemical structure and the way it interacts with the nervous system, ziconotide cannot be administered orally or through standard intravenous injection. Instead, it must be delivered directly into the cerebrospinal fluid that surrounds the spinal cord. This is achieved through intrathecal administration using a surgically implanted infusion pump system, allowing the medication to reach the targeted receptors in the dorsal horn of the spinal cord.

Regulatory References

  1. National Library of Medicine

What side effects are possible with Zicon?

Possible Side Effects and Safety Information

Zicon (Ciprofloxacin), a Fluoroquinolone antibiotic, has an officially defined safety profile categorized by regulatory authorities, such as the FDA and EMA. Adverse reactions are classified by frequency and grouped by the physiological systems they affect.

Frequency-Classified Adverse Reactions

The occurrence of possible side effects is formally categorized in regulatory documentation:

Frequency Examples of Officially Listed Side Effects
Common Nausea, Diarrhoea
Uncommon Headache, Dizziness, Vomiting, Insomnia, Arthralgia
Rare Peripheral neuropathy, Tendinitis, Psychotic reactions
Very Rare Tendon rupture, Seizures
Not Known Aortic aneurysm and dissection

System-Organ Class and Serious Reactions

Adverse effects are documented across various System-Organ Classes, including the Gastrointestinal Disorders, Nervous System Disorders, and Musculoskeletal and Connective Tissue Disorders. Official labels list several serious adverse reactions associated with this class of medicine, including Tendon Rupture, which may affect the Achilles tendon, and Aortic Aneurysm and Dissection.

Regulatory Safety Considerations

The official label contains specific safety notes, such as the caution that tendinitis and tendon rupture may occur during treatment or up to several months after discontinuation. Safety considerations also address specific patient populations: the medicine is generally not recommended in children and adolescents outside of restricted indications, and older adults have an officially noted increased risk of tendon disorders. Use should be avoided in individuals with a known history of serious adverse reactions to Fluoroquinolones.

Overdose and Emergency Response

Overdose and when to seek help

Overdosage of Zicon (Ciprofloxacin) is officially documented in regulatory sources as potentially manifesting with severe signs of Central Nervous System (CNS) toxicity, including dizziness, confusion, tremor, hallucinations, and convulsions (seizures). The physiological systems affected also include the Renal/Urinary system, with a risk of crystalluria (crystal formation in the urine), which may lead to acute renal failure. Serious risks include potential QT interval prolongation and severe aortic events such as aneurysm or dissection.


Required Emergency Actions

The regulatory guidance dictates that management must be symptomatic and supportive, as no specific antidote is known. Officially described supportive measures include the administration of activated charcoal and ensuring adequate hydration to prevent crystalluria. Monitoring of renal function and ECG monitoring are required due to the associated risks.


When to Seek Immediate Medical Help

Immediate medical attention or contact with emergency services is required upon recognition of any severe CNS symptoms or signs of life-threatening events. This includes severe and constant pain in the chest, stomach, or back, which may indicate an aortic event.

Therapeutic Uses of Zicon

Zicon is primarily used as an anti-infective agent to manage infections caused by susceptible bacterial pathogens, which may provide supportive relief to help ease the overall symptom burden and contributes to improved comfort during periods of acute episodes. Its use is relevant in clinical settings marked by heightened distress and instability.

It is commonly applied across conditions presenting with acute or disruptive symptom patterns, including complicated urinary tract infections (pyelonephritis), bone and joint infections, infectious diarrhea, nosocomial pneumonia, and for managing exposure to specific agents like Anthrax and Plague. It is used across domains where additional symptomatic support is needed.

Relief for Complicated Urinary and Abdominal Distress

Zicon is commonly applied in conditions marked by heightened symptoms in the urinary and gastrointestinal systems. The medicine helps address symptom clusters including painful or burning urination (dysuria) and debilitating diarrhea, which may assist with maintaining functional stability during these challenging phases.

Quick Fact: Relief for Dysuria and Systemic Discomfort

Symptom Focus Context of Use
Dysuria (painful urination) Relevant in situations with significant discomfort
Fever and Chills Used in settings marked by temporary physiological imbalance
Acute Pain Applied across domains where additional symptomatic support is needed

Managing Systemic Symptoms and Localized Pain

This agent is relevant in clinical settings that involve acute or unstable symptom patterns, tackling systemic illness indicators like high fever, chills, and general malaise, often seen in severe systemic infections. Furthermore, it addresses significant localized symptoms, including the acute pain associated with infections of the bone and joint or serious ear infections, which supports the patient during difficult episodes by easing distress.

Eligibility and Restrictions for Use

Zicon (Ciprofloxacin) eligibility is strictly defined by regulatory authorities to exclude high-risk populations. The medicine is contraindicated and must not be used in individuals with a known hypersensitivity to Ciprofloxacin or any other medicine in the Fluoroquinolone class. Concomitant use with the drug Tizanidine is also strictly prohibited, as is use in patients with a history of Myasthenia Gravis.

Age and Physiological Restrictions

Use is established for adults (18 years and older) for standard labeled indications. Use in children and adolescents under 18 years is generally not recommended but is permitted for a limited scope of severe infections, such as complicated urinary tract infections and inhalational Anthrax. The medicine is not recommended during pregnancy or breastfeeding.

Comorbidity Constraints

Specific restrictions and precautions apply to several patient groups. These include patients with a history of tendon disorders related to previous quinolone use, those with certain cardiac risk factors (e.g., prolonged QT interval), and patients with a known aortic aneurysm or risk of aortic dissection. Caution is also advised for older adults (60+), in cases of severe renal impairment, and for individuals with a predisposition to seizures.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for Zicon (Ciprofloxacin) strictly documents several types of interactions. Co-administration with Tizanidine is contraindicated due to Ciprofloxacin significantly increasing the Tizanidine plasma concentration, raising the risk of severe side effects. This combination is formally prohibited.

Ciprofloxacin is recognized as an inhibitor of the CYP1A2 enzyme, a pharmacokinetic interaction that decreases the clearance of certain co-administered medicines, including Theophylline and Caffeine, leading to elevated serum levels and potential toxicity. This metabolic impact necessitates monitoring for signs of CNS or other adverse reactions.

Official Interaction Restrictions

Interaction Type Interacting Substance/Class Regulatory Requirement
Timing-based Chelation Multivalent Cation-Containing Products (e.g., Antacids, Iron, Zinc supplements) Oral Ciprofloxacin must be taken 2 hours before or 6 hours after to ensure proper absorption.
Pharmacodynamic Warfarin May enhance the anticoagulant effect; requires prothrombin time and INR monitoring.
Pharmacodynamic NSAIDs Associated with an increased risk of CNS stimulation and seizures.

Furthermore, combining Zicon with Probenecid reduces Ciprofloxacin's renal clearance, increasing its systemic concentration. For specific drugs like Phenytoin and Methotrexate, regulatory documents require patient monitoring due to officially noted alterations in exposure.

Mechanism of Action

The mechanism of Zicon, whose active ingredient is Ciprofloxacin, is defined by its selective and lethal intervention in the core genetic machinery of bacterial cells, resulting in a bactericidal effect.

u1f52c Targeted Blockade of Essential Bacterial Enzymes

Ciprofloxacin acts as an inhibitor of two enzymes unique to bacteria: DNA Gyrase and Topoisomerase IV. The molecule binds to and stabilizes the complex where the enzyme is bound to the bacterial DNA, thereby preventing the enzymes from executing their roles in managing DNA structure.

u1f4a5 Cascade Resulting in Pathogen Destruction

This inhibition initiates a mechanistic cascade by forcing the enzymes to hold the DNA in a fractured state, causing catastrophic, unrepairable double-strand breaks in the bacterial genome. This unrecoverable genetic damage initiates a rapid cascade of cellular failure, leading directly to the death and irreversible destruction of the susceptible bacterial population.

u1f6a7 Mechanistic Limitations and Resistance

The mechanism's action is functionally constrained by evolved bacterial defenses, such as genetic mutations in the target enzymes (e.g., gyrA) that prevent drug binding. Additionally, the drug's access is restricted by the use of efflux pumps that actively expel the Ciprofloxacin molecule before it can cause sufficient DNA damage.

Dosage and Administration Information

Zicon is officially administered through the oral route (using immediate-release tablets, extended-release tablets, or suspension) and as an intravenous (IV) solution for infusion. The dosage is determined by the specific infection and its severity, with most adult regimens falling within a range of 250 mg to 750 mg per dose for oral forms, typically taken every 12 hours. Extended-release tablets, however, are generally scheduled for once-daily intake. The standard duration of use varies widely, ranging from short courses of 3 days for certain uncomplicated infections to specific long-term protocols, such as 60 days for post-exposure prophylaxis.


Key Administration Conditions

A key administration rule involves intake timing: Zicon tablets may be taken with or without food; however, they must be separated from products that contain multivalent cations, such as antacids, iron supplements, and milk or calcium-fortified juice. This separation must be maintained by taking the Zicon dose at least two hours before or six hours after these products.


Preparation and Specific Handling

Dosage forms have specific handling requirements: extended-release tablets must be swallowed whole and must not be crushed, split, or chewed, while the IV solution must be administered slowly over a period of 60 minutes. The liquid suspension must be shaken well prior to measurement.


Population-Specific Usage

The official protocol mandates that the dose frequency and amount must be adjusted for patients with renal impairment. The standard twice-daily frequency may be prolonged to every 18 or 24 hours based on the degree of kidney function. Pediatric dosing is determined by body weight, up to the maximum adult dose.

Recent Clinical Evidence

Zicon: Overview of Clinical Studies

This section outlines the research scope for Zicon (Ciprofloxacin), focusing on what clinical studies have examined for its primary uses as an anti-infective agent. The evidence describes the structure and findings of trials without implying claims of effectiveness or suitability for any individual.

Evidence for Use in Complicated Urinary Tract Infections (cUTI) and Pyelonephritis

Research for complicated urinary tract infections (cUTI) and kidney infections (pyelonephritis) primarily included short-term, randomized controlled trials. These studies were designed to explore how infectious organisms were eliminated, a process known as bacteriological clearance, and how symptom patterns were observed over the study period. Researchers studied outcomes related to physical discomfort, such as painful urination (dysuria), and changes related to systemic imbalance, such as fever. Studies reported measurements describing patterns where targeted organisms were no longer detectable in samples.

What is Still Uncertain About Zicon Research

Despite the established research base, several research limitations exist. For many indications, follow-up durations were limited to the immediate post-treatment period, meaning the durability of observed patterns over extended periods is not fully established. Furthermore, data for certain subgroups—such as older patients or those with specific underlying health conditions—remain insufficient. Research data for common infections in children also remain limited, and the potential development of resistance in infectious organisms is an area that continues to be monitored in research.

Summary of Evidence Status

Research Focus Study Types Examined Key Limitation Noted in Research
Effectiveness Randomized Controlled Trials (RCTs), Therapeutic Trials, Regulatory Summaries Limited long-term follow-up duration
Populations Primarily Adults; Limited data for certain special populations Insufficient data for certain subgroups
Outcomes Bacteriological Clearance, Symptom Patterns (Dysuria, Fever, Localized Pain) Varying sample sizes in earlier research

Key Studies & References Ciprofloxacin: MedlinePlus Drug Information

Frequently Asked Questions (FAQ)

Common questions about Zicon (FAQ)

Q: Is Zicon a pain reliever?

A: Zicon is officially classified as a Fluoroquinolone antibiotic. This means its core function, or mechanism of action, is bactericidal—it works to kill susceptible bacteria. Official regulatory documents indicate its role is to treat infections and it is not classified as an analgesic or pain reliever.


Q: What happens if I miss a dose of Zicon?

A: According to the patient information, official guidance is to take the missed dose as soon as it is remembered. However, if it is almost time for the next scheduled dose, the guidance is to skip the missed dose and continue with the regular schedule. Official guidance recommends against taking two doses at the same time.


Q: How quickly does Zicon start working?

A: The official pharmacokinetics information shows that Zicon typically reaches its maximum concentration in the bloodstream ( C max) about 1 to 2 hours after taking the oral tablet. This data describes how quickly the medicine gets into the system after it is administered.


Q: How long do the effects of Zicon last?

A: Regulatory documents state that the serum elimination half-life—the time it takes for half of the medicine to be eliminated from the bloodstream—is approximately 4 hours in people with normal kidney function. The urinary excretion of Zicon is virtually complete within 24 hours after dosing.


Q: Is it normal to feel tired when starting Zicon?

A: Severe tiredness is listed in official documentation as a serious adverse reaction categorized under Central Nervous System (CNS) effects. If this symptom occurs, official safety notes describe that patients should contact a healthcare provider for guidance regarding discontinuation, as this is a specific safety concern.


Q: Does Zicon interact with alcohol?

A: While there is no formally reported direct interaction with alcohol in the regulatory documents, official patient guidance notes that drinking alcohol while taking Zicon may worsen or increase the risk of experiencing certain side effects. These can include dizziness, headache, nausea, and potential liver problems.


Q: Where can I find official information about Zicon studies?

A: Official information regarding the research and trials that support Zicon's use can be found by consulting the Clinical Studies section of the FDA Prescribing Information. Additionally, the U.S. National Institutes of Health (NIH) maintains a public clinical trials registry.


Q: Is Zicon a controlled substance?

A: Zicon (Ciprofloxacin) is classified as a prescription antibiotic and is not listed as a controlled substance by the U.S. Drug Enforcement Administration (DEA). This classification confirms it is not regulated under the Controlled Substances Act.


Q: Is Zicon addictive?

A: Since Zicon is not classified as a controlled substance by the DEA, it does not carry a risk of physical dependence or addiction as defined by controlled substance laws.


Q: What should I do if my Zicon container is damaged?

A: Official information indicates the medicine must be kept in its original container with the lid tightly closed to protect it from moisture. Official information indicates Zicon should not be used if the original safety seal over the container opening is broken, missing, or if the container is otherwise damaged.


Q: Is Zicon gluten-free?

A: The inactive ingredients (excipients) used in Zicon are listed in the official drug label's Description section. Gluten is not typically a listed ingredient in these sections, but patients with Celiac disease or gluten sensitivity may wish to review the full inactive ingredient list with a healthcare provider for specific concerns.


Q: Does Zicon contain lactose?

A: According to the official list of inactive ingredients found in the product labeling, Zicon tablets and suspension do not include lactose as a component.


Q: Is Zicon the same as the generic name?

A: Zicon is the brand name that was initially given to the medicine. Its generic name, which is used across different manufacturers, is Ciprofloxacin.


Q: Does Zicon affect blood sugar levels?

A: Official warnings indicate that Zicon, like other antibiotics in its class, is associated with a risk of serious disturbances in blood sugar (glucose) levels. This includes the potential for both abnormally high blood sugar (hyperglycemia) and abnormally low blood sugar (hypoglycemia), which can, in rare cases, lead to coma.


Q: How long does Zicon stay in your system?

A: Official pharmacokinetic studies show that the active ingredient is eliminated from the body relatively quickly. The urinary excretion of Zicon is virtually complete within 24 hours after the administration of a single dose.


Q: Can Zicon make me drowsy?

A: Drowsiness or changes in mental state are listed in the regulatory documents as a serious adverse reaction falling under the category of Central Nervous System (CNS) effects. If this is experienced, guidance from a healthcare professional should be sought.


Q: Are there alternatives to Zicon that work similarly?

A: The FDA Boxed Warning advises that Zicon should be reserved for use in certain conditions only when there are no alternative treatment options available. This regulatory requirement is an official acknowledgment that other treatments may exist for the conditions Zicon is used to treat.


Q: What is the name of the company that makes Zicon?

A: According to official regulatory filings, the original New Drug Application (NDA) sponsor for the brand name Zicon (known as Cipro or Cipro XR in the U.S.) was Bayer Healthcare Pharmaceuticals Inc.


Q: Are there specific warnings for people with liver problems using Zicon?

A: Official labeling notes that Zicon has been associated with changes in liver enzyme levels and, in rare instances, liver damage. The documents also state that the full details of how Zicon behaves in patients with acute hepatic insufficiency (liver problems) have not been completely studied.


Q: Does Zicon have a Black Box Warning?

A: Yes, Zicon carries an FDA Boxed Warning (often called a 'Black Box Warning') prominently displayed in its labeling. This is required for medicines with certain serious risks, and Zicon's warning covers potential serious adverse reactions, including tendon damage, nerve damage (peripheral neuropathy), and Central Nervous System (CNS) effects.


Q: Does Zicon affect sleep?

A: Insomnia—difficulty falling or staying asleep—is an officially reported uncommon side effect of Zicon listed in the regulatory documents under Nervous System Disorders.


Q: Is it safe to take Zicon with vitamins or supplements?

A: Supplements that contain multivalent cations, such as iron, zinc, magnesium, and calcium, can significantly reduce how much Zicon your body absorbs. Therefore, official guidance states that these supplements must be taken at least 2 hours before or 6 hours after the Zicon dose.


Q: Are there any food restrictions while taking Zicon?

A: Zicon should be separated from dairy products (like milk or yogurt) or calcium-fortified juices when they are taken alone, as the high mineral content can interfere with drug absorption. However, official information confirms that Zicon can be taken with a meal that contains these products.


Q: Do older adults need a special check before using Zicon?

A: Official labeling notes that older adults (60 years and older) are at an increased risk of certain serious adverse reactions, particularly tendon disorders. This increased risk suggests the need for careful monitoring and close supervision by a healthcare provider.

How should Zicon be stored and disposed of?

The storage and disposal of Zicon (Ciprofloxacin) must strictly adhere to the conditions mandated in the official regulatory labeling.

Storage Requirements

Condition Requirement
Temperature Store at controlled room temperature, between 20°C and 25°C (68°F and 77°F).
Container Keep the bottle tightly closed and store the medicine in its original container to protect it from moisture.
Child Safety It is required that the medicine be stored out of the sight and reach of children.

Disposal Instructions

Unused or expired Zicon must not be flushed down a toilet or poured into a drain. Disposal should be managed through an authorized medication take-back program or by following official household disposal procedures for medicines when no take-back program is available.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Zicon found in:

A-Z Index: